Journey to Anticoagulant Access Following Payer Rejection of Apixaban
November 7th 2023Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.
Read More
2 Clarke Drive
Cranbury, NJ 08512